Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.
Advertisement
You can also search for this author in PubMed Google Scholar
Psychedelic drugs such as MDMA and psilocybin, the hallucinogenic compound found in magic mushrooms, have promised to revolutionize psychiatric treatments. Now, a small trial in military veterans suggests that a lesser-known, potent psychedelic drug called ibogaine could be used to treat traumatic brain injury (TBI). One month after ibogaine treatment, the veterans reported that TBI symptoms such as post-traumatic stress disorder (PTSD) and depression had decreased by more than 80%, on average1.
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
doi: https://doi.org/10.1038/d41586-024-00012-z
Cherian, K. N. et al. Nature Med. https://doi.org/10.1038/s41591-023-02705-w (2024).
Article Google Scholar
Alper, K. R., Lotsof, H. S., Frenken, G. M. N., Luciano, D. J &. Bastiaans, J. Am. J. Addictions 8, 234–242 (1999).
Article Google Scholar
Nardou, R. et al. Nature 618, 790–798 (2023).
Article PubMed Google Scholar
Download references
Reprints and permissions
Psychedelic treatments are speeding towards approval — but no one knows how they work
Taking the tripping out of psychedelic medicine
Hope that psychedelic drugs can erase trauma
Your brain on psychedelics
Psychedelics re-engineered for potential use in the clinic
Pregnancy advances your ‘biological’ age — but giving birth turns it back
News
First pig kidney transplant in a person: what it means for the future
News
Cutting-edge CAR-T cancer therapy is now made in India — at one-tenth the cost
News
Ketamine is in the spotlight thanks to Elon Musk — but is it the right treatment for depression?
News Explainer
COVID’s toll on the brain: new clues emerge
News
Can lessons from infants solve the problems of data-greedy AI?
News & Views
Non-neuronal brain cells modulate behaviour
News & Views
Synchronized neuronal activity drives waste fluid flow
News & Views
A model of human neural networks reveals NPTX2 pathology in ALS and FTLD
Article
We are seeking a highly motivated PhD and/or MD graduate to work in the Cardiovascular research lab in the Tulane University Department of Medicine.
New Orleans, Louisiana
School of Medicine Tulane University
Channing Division of Network Medicine, Brigham and Women’s Hospital, and Harvard Medical School are seeking applicants for 3 postdoctoral positions.
Boston, Massachusetts
Brigham and Women's Hospital (BWH)
Memphis, Tennessee
The University of Tennessee Health Science Center (UTHSC)
Join our multidisciplinary and stimulative research environment as Associate Professor in Modeling of Plant Stress Responses
Umeå (Kommun), Västerbotten (SE)
Umeå Plant Science Centre and Integrated Science Lab
Houston, Texas (US)
Baylor College of Medicine (BCM)
Psychedelic treatments are speeding towards approval — but no one knows how they work
Taking the tripping out of psychedelic medicine
Hope that psychedelic drugs can erase trauma
Your brain on psychedelics
Psychedelics re-engineered for potential use in the clinic
An essential round-up of science news, opinion and analysis, delivered to your inbox every weekday.
Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.
© 2024 Springer Nature Limited